Age-related Macular Degeneration
Conditions
Interventions
1:intravitreal injection of triamcinolone acetonide
2:intravitreal injection of triamcinolone acetonide combined with ranibizumab
Sponsors
Jingzhou Central Hospital
Eligibility
Sex/Gender
All
Age
50 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients who are in line with the Clinical diagnostic criteria for age-related macular degeneration proposed by the Chinese Medical Association ophthalmology eye fundus disease group in 1986; 2. Patients who have exudative age-related macular degeneration as confirmed by indocyanine green angiography; 3. Patients who are for the first time confirmed as having age-related macular degeneration and undergo relevant treatments; 4. Aged over 50 years; 5. Irrespective of genders; 6. Provision of signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients who are difficult to distinguish from other retinal macular degeneration by fundus examination; 2. Unwilling to receive treatment regimen.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Foveal retinal thickness; | — |
Secondary
| Measure | Time frame |
|---|---|
| The best corrected visual acuity;Intraocular pressure;Quality of life scores;The incidence of adverse events; | — |
Countries
China
Contacts
Public ContactFen Wei
Jingzhou Central Hospital
Outcome results
None listed